secwatch.observer — SEC 8-K summary
======================================

Issuer:     IONIS PHARMACEUTICALS INC (IONS)
CIK:        0000874015
Form:       8-K
Filed at:   2026-06-08T16:49:43+00:00
Accession:  0001140361-26-024407
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ionis appoints Ludwig Hantson to board; shareholders approve equity plan amendments
--------------------------------------------------------------------------------

- Ludwig Hantson, former Alexion CEO, appointed to board effective June 4, 2026.
- Peter Reikes also appointed to board; directors Joseph Wender and Lynne Parshall retired.
- Shareholders approved increase of 2011 equity plan by 9.5M shares to 52M total.
- ESPP amended to add 750k shares and remove termination date; Ernst & Young ratified as auditor.
- Advisory vote on executive compensation passed with ~135.5M votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874015/000114036126024407/0001140361-26-024407-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874015/000114036126024407/ef20075669_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-024407

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer